Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.17153
Abstract: Key Points Question Is the risk of ventricular tachyarrhythmia similar between women and men with an implantable cardioverter-defibrillator for primary prevention? Findings In this cohort study of 4506 patients with an implantable cardioverter-defibrillator, women and… read more here.
Keywords: implantable cardioverter; cardioverter defibrillator; defibrillator; primary prevention ... See more keywords
Posttraumatic stress disorder and mortality in VA patients with implantable cardioverter‐defibrillators
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.22945
Abstract: The association between posttraumatic stress disorder (PTSD) and mortality in patients undergoing implantable cardioverter‐defibrillator (ICD) placement has not been evaluated in US veterans. read more here.
Keywords: implantable cardioverter; posttraumatic stress; mortality patients; stress disorder ... See more keywords
State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cardiology"
DOI: 10.1002/clc.23432
Abstract: Within the last decade, implantable cardioverter‐defibrillator (ICD) systems with non‐transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of… read more here.
Keywords: consensus; implantable cardioverter; non transvenous; cardioverter defibrillator ... See more keywords
Outcomes of implantable cardioverter‐defibrillator implantation in HIV‐infected patients: A single‐center retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23868
Abstract: HIV‐infected individuals have a known increased risk of sudden cardiac death (SCD) compared to uninfected individuals. Implantable cardioverter‐defibrillators (ICDs) are standard therapy for preventing SCD; however, there is limited data on the outcomes of ICDs… read more here.
Keywords: hiv; outcomes implantable; hiv infected; cardioverter defibrillator ... See more keywords
Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14249
Abstract: This systematic review evaluated the clinical effectiveness and safety of subcutaneous implantable cardioverter‐defibrillator (S‐ICD) in patients at an increased risk of sudden cardiac death and with an ICD indication for primary or secondary prevention. A… read more here.
Keywords: systematic review; observational studies; subcutaneous implantable; effectiveness safety ... See more keywords
Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.1192
Abstract: There is limited information on the outcomes after primary prevention implantable cardioverter‐defibrillator (ICD) implantation in patients with heart failure (HF) and diabetes. This analysis evaluates the effectiveness of a strategy of ICD plus medical therapy… read more here.
Keywords: implantable cardioverter; cardioverter defibrillators; heart; heart failure ... See more keywords
Should we rethink the indications for implantable cardioverter‐defibrillators in non‐ischaemic dilated cardiomyopathy?
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.948
Abstract: Heart failure (HF) represents a major cause of morbidity and health care expenditure globally,1 and increases the risk for sudden cardiac death (SCD). In the USA, about 325 000 adults die from SCD every year,… read more here.
Keywords: heart failure; scd; non ischaemic; icd implantation ... See more keywords
The role of multimodality imaging in the selection for implantable cardioverter‐defibrillators in heart failure: A narrative review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Ultrasound"
DOI: 10.1002/jcu.23281
Abstract: Advanced pharmacologic and interventional therapies have improved survival in heart failure. Implantable cardioverter‐defibrillators (ICD) have been shown to reduce mortality in patients with heart failure, but the benefit appears to be uneven in this population.… read more here.
Keywords: cardioverter defibrillators; heart failure; heart; implantable cardioverter ... See more keywords
Simultaneous leadless pacemaker and subcutaneous implantable cardioverter‐defibrillator implantation—When vascular options have run out
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12140
Abstract: An end‐stage renal failure patient who was planned for a left brachioaxillary arteriovenous graft required an implantable cardioverter‐defibrillator for secondary prevention of ventricular tachycardia and a pacemaker for complete heart block but was found to… read more here.
Keywords: pacemaker; implantable cardioverter; cardioverter defibrillator; implantation ... See more keywords
Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12234
Abstract: Clinical features and complications of subcutaneous implantable cardioverter‐defibrillator (S‐ICD) implantation for Brugada syndrome have not been well studied. read more here.
Keywords: subcutaneous implantable; brugada syndrome; implantable cardioverter; complications subcutaneous ... See more keywords
RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12551
Abstract: An implantable cardioverter defibrillator (ICD) is the most reliable therapeutic device for preventing sudden cardiac death in patients with sustained ventricular tachycardia (VT). Regarding its effectiveness, targeted VT is defined based on the tachyarrhythmia cycle… read more here.
Keywords: interval variability; ventricular tachycardia; variability; therapy ... See more keywords